Brief communications 277 specific renal lesions described in this case have been reported 2. in swine with exudative epidermitis. 3, 6 A computerized literature search revealed reports of isolation of S. hyicus from cattle, dogs, cats, swine, and poultry 3 ' but not from the skin of goats.
Detection and elimination of carrier animals in a dairy herd persistently infected with bovine viral diarrhea virus
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Cattle persistently infected with bovine viral diarrhea virus (BVDV) are known to shed large amounts of virus throughout their life. 5, 9 These immune-tolerant animals appear to be more significant sources of virus on a farm than are immunocompetent cattle that undergo acute BVDV infection. 5 Persistently infected immune-tolerant cattle that reach breeding age may produce persistently infected offspring. 6,1o On an average, l-2% of cattle are persistently infected with BVDV, 3, 7 but this rate may be as high as 9% in some herds. 3 In herds with a high prevalence of BVDV infection/disease, the percentage of persistently infected cattle may be correspondingly higher.
Detection and elimination of persistently infected cattle is an essential component of a BVDV control program in an infected herd. 8 We report here on the apparent improvement in calf viability and overall health of a herd of dairy cattle affected with BVDV following implementation of a control program consisting of booster vaccinations and elimination of immune-tolerant carrier animals. Additionally, we report the results of an attempt to produce mucosal disease in a calf that was found to be an immune-tolerant carrier of BVDV and suggest practical measures for managing BVDV-infected dairy herds.
A Minnesota dairy herd suffered severe neonatal calf losses in 1986 and 1987 due to BVDV infection manifested pri- Presented at the 31st Annual Meeting of the AAVLD, Little Rock, AR, October 15-18, 1988.
Received for publication October 19, 1988. marily by neonatal calf diarrhea ( Table 1 ). Upon sampling the entire herd, virus neutralization (VN) titers of many cows were found to be low. 11 The virus was isolated from buffy coats of blood and from serum samples of several cows and calves. Two booster vaccinations were administered at a 3-week interval using a killed BVDV vaccine. The herd was re-bled 21 days after the last vaccination and several calves were found to be immune-tolerant carriers of noncytopathic BVDV as determined by virus isolation from their buffy coats and by low VN titers (1:2 and 1:4) after booster vaccinations. After the removal of immune-tolerant carriers and the administration of booster vaccinations, calf viability and milk production improved greatly in the herd ( Table 1 ). The newborn calves were larger and more vigorous at birth and fewer repeat breeders were reported. Currently, the animals in the herd are given booster vaccinations with a killed bovine viral diarrhea (BVD) vaccine once every year in the spring; calves receive 2 immunizations 3 weeks apart starting at approximately 4 months of age. A 6-month-old Holstein calf Y24) from this herd was donated to the College of Veterinary Medicine, University of Minnesota. The calf had been removed from the herd because of persistent isolation of BVDV from buffy coat samples and because it maintained a low VN titer (1:2 to 1:4) to BVDV. The calf was thin and small for its age and weighed 79.5 kg. An attempt was made to produce mucosal disease in this calf by inoculating it with 2 different strains of cytopathic BVDV given 7 weeks apart. The animal was monitored prior to, during, and after virus inoculation for clinical signs, virus shedding, antibody titers, and neutrophil counts. Virus isolation was attempted on heparinized blood, saliva, tears, urine, and feces to document viral shedding. The calf was inoculated intravenously with cytopathic BVDV * Fifteen calves died before April and 9 died after April. Booster vaccinations were done in June.
† Until September 1. ‡ Six calves died of hypothermia-starvation complex, 1 aborted, and 1 died of bloat. on 2 different occasions: on day 1 with 1.2 x l0 6 TCID 50 of Georgia a strain and on day 52 with 6.0 x l0 6 TCID 50 of NADL b strain. Virus neutralization titers, body temperatures, neutrophil counts, and virus isolation results after virus inoculations are shown in Table 2 . The calf became mildly depressed and pyrexic and exhibited mild dyspnea after challenge, but did not lose appetite or become severely depressed. The stools were normal throughout the postinoculation period. The calf's general attitude and well-being appeared to improve slightly during the second postinoculation period up to the time of necropsy. Throughout the pre-and postinoculation periods, the calf continued to shed noncytopathic virus in saliva, feces, tears, and urine. Titration of virus from urine collected during the preinoculation period revealed a virus titer of l0 2 TCID 50 /ml. When it became apparent that the calf would not develop clinical mucosal disease, euthanasia was performed 107 days after the initial virus challenge.
On necropsy, the cervical and thoracic thymus were normal in size. The ventral aspects of the cranial and middle lobes of both lungs were severely consolidated. There was no evidence of oral, esophageal, or gastric erosions or ulcers. All histologic lesions were confined to the respiratory tract. Acute suppurative pneumonia, mild suppurative tracheitis, and lymphadenitis of the mediastinal lymph nodes were observed. No lesions were found in sections of jejunum, ileum, or colon, and there was no evidence of lymphocytic depletion from Peyer's patches of the ileum, thymus, spleen, or mesenteric lymph nodes. A pure culture of Hemophilus somnus was isolated from lung tissue, and noncytopathic BVDV was isolated from intestine, mesenteric lymph node, kidney, thymus, lung, spleen, trachea, and feces.
The improvement in calf viability and milk production (Table 1) emphasizes the benefits of attempts to eliminate or decrease the spread of BVDV infection in the herd. The control procedure was based on identification and elimination of immune-tolerant carrier animals and boosting herd immunity by an adequate vaccination program. Virus neutralization titers found at the initial testing of the herd were believed to be low partly because booster vaccinations with killed BVD vaccine were not given. 11 The continued shedding of large amounts of virus in tears, saliva, urine, and feces of the immune-tolerant animal stresses the importance of removal of such carriers from a herd. Their removal prevents the spread of the virus to susceptible animals, especially to pregnant females. It was surprising that instead of developing signs of mucosal disease following challenge with cytopathic BVDV, the calf developed a high antibody titer to the inoculated virus ( Table 2 ). The earlier lack of serologic response to vaccination in this calf may have been due to inadequate antigenic mass in the killed vaccine used in the face of existing passive immunity. The serologic response following live virus challenge may have been due to a greater stimulation of the immune system by the large amounts of replicating virus. The isolation of noncytopathic BVDV from many organs of this calf at necropsy was unexpected. These findings emphasize that immune-tolerance to BVDV is restricted to closely related strains of virus or to closely related BVD viral proteins. 2, 4 It is a common practice to bleed a herd, identify animals with low VN titers, revaccinate the herd, and re-bleed for antibody detection to identify immune-tolerant carriers. The animals that do not show a rise in antibody titer or die from mucosal disease are considered immune-tolerant carriers. In view of the results of this study and the reports of others, 2 this practice probably is not valid, because the vaccine strain may be different enough to induce seroconversion even in an immune-tolerant carrier animal; consequently the animal may not be removed from the herd.
From our experiences with this particular herd, it is believed that the most reliable method for detection of BVD immune-tolerant carriers is the persistent isolation of the virus from buffy coats" and the finding of low VN titers in nonvaccinated animals. Attempts to detect the virus by direct fluorescence assay methods in buffy coat smears as described by others 1 have been unrewarding in our studies. ll The economic gains justify the cost of identifying and removing immune-tolerant carrier animals from a dairy herd. 
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